Breaking News Instant updates and real-time market news.

LYRA

Lyra Therapeutics

$11.15 /

-0.15 (-1.33%)

18:14
04/11/21
04/11
18:14
04/11/21
18:14

Lyra Therapeutics presents full data set from LANTERN Phase 2 study

Lyra Therapeutics presented data from its Phase 2 LANTERN study of LYR-210, the company's lead long-acting product candidate for chronic rhinosinusitis, at the Combined Otolaryngology Spring Meetings 2021. LYR-210 is an investigational product candidate designed to be administered in-office and to deliver a sustained release therapeutic for up to six months at difficult-to-access nasal inflammation sites, as a non-invasive alternative to surgery for patients who have failed medical management. Lyra reported positive topline data from the LANTERN study in December 2020. The COSM oral presentation, titled Long-acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study, contains the full 24-week data set from the company's Phase 2 clinical trial of LYR-210. Previously unpublished data included: improvement from baseline in bilateral ethmoid Zinreich scores by magnetic resonance imaging; symptom improvement in both polyp and non-polyp patients; and the need for and use of rescue medication during the trial. In Polyp vs Non-Polyp patients, symptom improvement was observed in both polyp and non-polyp patients, with 100% of patients at the 7500microgram dose in each group achieving the minimal clinically important difference of 8.9 points for SNOT-22 total score by week 24, with a single administration of LYR-210. In the LANTERN study, subjects underwent paranasal sinus MRI at baseline as well as at the end of treatment. LYR-210 achieved improvement in bilateral ethmoid Zinreich scores at week 24 in a dose-dependent manner, providing evidence of disease modification, with the 7500microgram dose achieving significant improvement compared to control between the two timepoints. Only 1 patient in the 7500microgram group and 2 patients in the 2500microgram group required a rescue treatment compared to 7 patients in the control group over the 24-week treatment period. The first incidence of rescue treatment in the control group occurred at week 2, while the only patient to require rescue treatment in the 7500microgram group did not require rescue treatment until after week 18. As such, LYR-210 reduced the need for rescue treatment. The need for rescue treatment in the LANTERN study was determined by the treating physician. Separately, Lyra has shared an analysis of the LANTERN study focused on a composite of three of the cardinal symptoms of CRS. Lyra announced an analysis of a composite score of three cardinal symptoms of CRS, which includes nasal blockage, nasal discharge and facial pain, which are the most prevalent symptoms for surgically naive CRS patients both with and without nasal polyps. With a single administration, LYR-210 achieved statistically significant improvement in the 3CS composite score compared to control at week 24 and at earlier timepoints.

  • 26

    May

  • 01

    May

LYRA Lyra Therapeutics
$11.15 /

-0.15 (-1.33%)

12/07/20 BofA
Lyra Therapeutics price target raised to $26 from $19 at BofA
05/26/20 BTIG
Lyra Therapeutics initiated with a Buy at BTIG
05/26/20 Jefferies
Jefferies starts Lyra Therapeutics at Buy with $24 price target
05/26/20 BofA
BofA starts Lyra Therapeutics at Buy with $21 price target

TODAY'S FREE FLY STORIES

Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 » 16:05
05/07/21
05/07
16:05
05/07/21
16:05
IWM

iShares Trust Russell 2000 Index Fund

$225.28 /

+2.52 (+1.13%)

, RUT

Russell 2000 Index

/

+

The Russell 2000 (RUT) is…

The Russell 2000 (RUT) is set to end off the lows of the week, but essentially flat against the prior-week close. At the last price of 2268, resistance for the coming week is in the range of 2275-2350 (close to the all-time high). Support is in the range of 2250-2200. The weakest groups were Health Care and Technology by a wide margin. Basic Materials and the Financials were the standouts on the upside.

ShowHide Related Items >><<
IWM iShares Trust Russell 2000 Index Fund
$225.28 /

+2.52 (+1.13%)

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
RUT Russell 2000 Index
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
IWM iShares Trust Russell 2000 Index Fund
$225.28 /

+2.52 (+1.13%)

IWM iShares Trust Russell 2000 Index Fund
$225.28 /

+2.52 (+1.13%)

IWM iShares Trust Russell 2000 Index Fund
$225.28 /

+2.52 (+1.13%)

RUT Russell 2000 Index
/

+

On The Fly
Bet On It: Ohio senators lay out gaming bill » 16:01
05/07/21
05/07
16:01
05/07/21
16:01
DKNG

DraftKings

$48.67 /

-3.22 (-6.21%)

, PDYPY

Flutter Entertainment

$102.67 /

+0.87 (+0.85%)

, MLCO

Melco Resorts & Entertainment

$18.21 /

-0.17 (-0.92%)

, MGM

MGM Resorts

$39.84 /

+0.92 (+2.36%)

, GENI

Genius Sports

$18.89 /

+1.03 (+5.77%)

, PENN

Penn National

$86.68 /

+2.68 (+3.19%)

, CZR

Caesars

$105.13 /

+2.94 (+2.88%)

Welcome to the latest…

ShowHide Related Items >><<
DKNG DraftKings
$48.67 /

-3.22 (-6.21%)

PDYPY Flutter Entertainment
$102.67 /

+0.87 (+0.85%)

MLCO Melco Resorts & Entertainment
$18.21 /

-0.17 (-0.92%)

MGM MGM Resorts
$39.84 /

+0.92 (+2.36%)

GENI Genius Sports
$18.89 /

+1.03 (+5.77%)

PENN Penn National
$86.68 /

+2.68 (+3.19%)

CZR Caesars
$105.13 /

+2.94 (+2.88%)

DKNG DraftKings
$48.67 /

-3.22 (-6.21%)

13:40 Today Goldman Sachs
DraftKings 'beat and raise' sustains bull case, says Goldman Sachs
07:47 Today Morgan Stanley
DraftKings revenue beat 'very impressive,' says Morgan Stanley
05/03/21
Fly Intel: Top five analyst upgrades
05/03/21 Cowen
DraftKings upgraded to Outperform from Market Perform at Cowen
PDYPY Flutter Entertainment
$102.67 /

+0.87 (+0.85%)

10:23 Today Berenberg
Flutter Entertainment price target raised to 14,700 GBp from 14,300 GBp at Berenberg
05/04/21 RBC Capital
Flutter Entertainment price target lowered to 16,000 GBp from 17,000 GBp at RBC Capital
04/30/21 JPMorgan
Flutter price target lowered to 15,970 GBp from 16,233 GBp at JPMorgan
04/30/21 Deutsche Bank
Flutter price target raised to 16,285 GBp from 15,485 GBp at Deutsche Bank
MLCO Melco Resorts & Entertainment
$18.21 /

-0.17 (-0.92%)

02/25/21 CLSA
Melco Resorts & Entertainment upgraded to Outperform from Underperform at CLSA
01/07/21 Macquarie
Melco Resorts & Entertainment downgraded to Neutral from Outperform at Macquarie
11/17/20 JPMorgan
Melco Resorts & Entertainment price target raised to $25 from $23 at JPMorgan
11/05/20 Roth Capital
Roth Capital trims price target on 'go-to Macau name' Melco Resorts to $30
MGM MGM Resorts
$39.84 /

+0.92 (+2.36%)

05/04/21 BofA
MGM Growth double-downgraded to Underperform from Buy at BofA
04/29/21 Jefferies
MGM Resorts price target raised to $53 from $50 at Jefferies
04/29/21 Deutsche Bank
MGM Resorts price target raised to $42 from $35 at Deutsche Bank
04/27/21 Truist
MGM Resorts price target raised to $43 from $38 at Truist
GENI Genius Sports
$18.89 /

+1.03 (+5.77%)

04/26/21 Oppenheimer
Genius Sports initiated with an Outperform at Oppenheimer
02/23/21 Benchmark
dMY Technology II initiated with a Buy at Benchmark
PENN Penn National
$86.68 /

+2.68 (+3.19%)

07:18 Today Morgan Stanley
Penn National selloff 'feels overdone' after 'strong' Q1, says Morgan Stanley
05/06/21 Stifel
Stifel wouldn't expect Penn National Q1 beat to drive shares 'materially higher'
04/26/21 Needham
Penn National initiated with a Buy at Needham
04/21/21 Goldman Sachs
Penn National price target raised to $158 from $153 at Goldman Sachs
CZR Caesars
$105.13 /

+2.94 (+2.88%)

05/06/21 KeyBanc
Caesars price target raised to $125 from $110 at KeyBanc
05/05/21 Deutsche Bank
Caesars price target raised to $126 from $120 at Deutsche Bank
04/27/21 Truist
Caesars price target raised to $120 from $100 at Truist
04/27/21 Deutsche Bank
Caesars price target raised to $120 from $65 at Deutsche Bank
DKNG DraftKings
$48.67 /

-3.22 (-6.21%)

MLCO Melco Resorts & Entertainment
$18.21 /

-0.17 (-0.92%)

MGM MGM Resorts
$39.84 /

+0.92 (+2.36%)

PENN Penn National
$86.68 /

+2.68 (+3.19%)

CZR Caesars
$105.13 /

+2.94 (+2.88%)

  • 07
    Oct
  • 29
    Sep
  • 25
    Sep
  • 19
    Jun
  • 12
    May
DKNG DraftKings
$48.67 /

-3.22 (-6.21%)

PDYPY Flutter Entertainment
$102.67 /

+0.87 (+0.85%)

MGM MGM Resorts
$39.84 /

+0.92 (+2.36%)

PENN Penn National
$86.68 /

+2.68 (+3.19%)

CZR Caesars
$105.13 /

+2.94 (+2.88%)

DKNG DraftKings
$48.67 /

-3.22 (-6.21%)

PDYPY Flutter Entertainment
$102.67 /

+0.87 (+0.85%)

MLCO Melco Resorts & Entertainment
$18.21 /

-0.17 (-0.92%)

MGM MGM Resorts
$39.84 /

+0.92 (+2.36%)

GENI Genius Sports
$18.89 /

+1.03 (+5.77%)

PENN Penn National
$86.68 /

+2.68 (+3.19%)

CZR Caesars
$105.13 /

+2.94 (+2.88%)

DKNG DraftKings
$48.67 /

-3.22 (-6.21%)

MLCO Melco Resorts & Entertainment
$18.21 /

-0.17 (-0.92%)

MGM MGM Resorts
$39.84 /

+0.92 (+2.36%)

GENI Genius Sports
$18.89 /

+1.03 (+5.77%)

PENN Penn National
$86.68 /

+2.68 (+3.19%)

CZR Caesars
$105.13 /

+2.94 (+2.88%)

Hot Stocks
SC Health Corporation (Class A Units) trading resumes  16:00
05/07/21
05/07
16:00
05/07/21
16:00
 
Hot Stocks
SC Health Corporation (Class A Units) trading halted, volatility trading pause  15:52
05/07/21
05/07
15:52
05/07/21
15:52
 
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 » 15:49
05/07/21
05/07
15:49
05/07/21
15:49
XLRE

Real Estate SPDR

$42.34 /

+0.49 (+1.17%)

, XLY

Consumer Discretionary Sector SPDR

$177.77 /

+1.76 (+1.00%)

, XLK

Technology Select Sector SPDR

$139.19 /

+1.41 (+1.02%)

, XLF

Financial Select Sector

$37.79 /

+0.225 (+0.60%)

, XLE

Energy Select Sector SPDR

$53.66 /

+0.985 (+1.87%)

, XLB

S&P Select Materials SPDR

$87.83 /

+0.81 (+0.93%)

, SPY

SPDR S&P 500 ETF Trust

$422.64 /

+3.56 (+0.85%)

, SPX

S&P 500

/

+

At time of writing the…

At time of writing the S&P 500 was off its session highs but still set to close at a new all-time high. With price last at 4233, there is no resistance overhead. A possible upside range for next week would be 4240-4300. Support is in the range of 4220-4160. The leading sectors for the week were Basic Materials (XLB), Energy (XLE), and the Financials (XLF). On the downside the weakest sectors were Technology (XLK), Consumer Discretionary (XLY), and Real Estate (XLRE).

ShowHide Related Items >><<
XLE Energy Select Sector SPDR
$53.66 /

+0.985 (+1.87%)

SPY SPDR S&P 500 ETF Trust
$422.64 /

+3.56 (+0.85%)

SPX S&P 500
/

+

XLRE Real Estate SPDR
$42.34 /

+0.49 (+1.17%)

XLY Consumer Discretionary Sector SPDR
$177.77 /

+1.76 (+1.00%)

03/12/21
On The Fly: Weekly technical notes for S&P 500
XLK Technology Select Sector SPDR
$139.19 /

+1.41 (+1.02%)

06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
XLF Financial Select Sector
$37.79 /

+0.225 (+0.60%)

03/12/21
On The Fly: Weekly technical notes for S&P 500
XLE Energy Select Sector SPDR
$53.66 /

+0.985 (+1.87%)

03/12/21
On The Fly: Weekly technical notes for S&P 500
07/06/20 Goldman Sachs
Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs
XLB S&P Select Materials SPDR
$87.83 /

+0.81 (+0.93%)

03/12/21
On The Fly: Weekly technical notes for S&P 500
06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
SPY SPDR S&P 500 ETF Trust
$422.64 /

+3.56 (+0.85%)

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$422.64 /

+3.56 (+0.85%)

SPX S&P 500
/

+

XLY Consumer Discretionary Sector SPDR
$177.77 /

+1.76 (+1.00%)

XLF Financial Select Sector
$37.79 /

+0.225 (+0.60%)

XLE Energy Select Sector SPDR
$53.66 /

+0.985 (+1.87%)

XLB S&P Select Materials SPDR
$87.83 /

+0.81 (+0.93%)

SPY SPDR S&P 500 ETF Trust
$422.64 /

+3.56 (+0.85%)

SPX S&P 500
/

+

XLRE Real Estate SPDR
$42.34 /

+0.49 (+1.17%)

XLY Consumer Discretionary Sector SPDR
$177.77 /

+1.76 (+1.00%)

XLK Technology Select Sector SPDR
$139.19 /

+1.41 (+1.02%)

XLF Financial Select Sector
$37.79 /

+0.225 (+0.60%)

XLE Energy Select Sector SPDR
$53.66 /

+0.985 (+1.87%)

XLB S&P Select Materials SPDR
$87.83 /

+0.81 (+0.93%)

SPY SPDR S&P 500 ETF Trust
$422.64 /

+3.56 (+0.85%)

SPX S&P 500
/

+

Hot Stocks
Amazon plans to build first robotics fulfillment center in Louisiana » 15:36
05/07/21
05/07
15:36
05/07/21
15:36
AMZN

Amazon.com

$3,304.00 /

-3 (-0.09%)

Amazon plans to open its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

05/04/21 R5 Capital
Amazon.com upgraded to Buy from Hold at R5 Capital
04/30/21 Evercore ISI
Amazon price target raised to $4,500 from $4,000 at Evercore ISI
04/30/21 MKM Partners
Amazon.com price target raised to $4,075 from $3,975 at MKM Partners
04/30/21 Raymond James
Amazon.com price target raised to $4,125 from $4,000 at Raymond James
AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

Options
Univar options imply 8.3% move in share price post-earnings » 15:34
05/07/21
05/07
15:34
05/07/21
15:34
UNVR

Univar

$24.32 /

+0.05 (+0.21%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNVR Univar
$24.32 /

+0.05 (+0.21%)

UNVR Univar
$24.32 /

+0.05 (+0.21%)

03/08/21 BofA
Univar downgraded to Underperform from Buy at BofA
11/06/20 Goldman Sachs
Univar downgraded to Neutral from Buy at Goldman Sachs
UNVR Univar
$24.32 /

+0.05 (+0.21%)

UNVR Univar
$24.32 /

+0.05 (+0.21%)

Recommendations
Standex price target raised to $113 from $110 at Barrington » 15:32
05/07/21
05/07
15:32
05/07/21
15:32
SXI

Standex

$101.80 /

+3.445 (+3.50%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SXI Standex
$101.80 /

+3.445 (+3.50%)

SXI Standex
$101.80 /

+3.445 (+3.50%)

03/01/21 Barrington
Standex price target raised to $110 from $101 at Barrington
02/05/21 Barrington
Standex price target raised to $101 from $97 at Barrington
01/28/21 Barrington
Standex price target raised to $97 from $94 at Barrington
01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
SXI Standex
$101.80 /

+3.445 (+3.50%)

SXI Standex
$101.80 /

+3.445 (+3.50%)

Recommendations
Fidus Investment price target raised to $19 from $16 at Raymond James » 15:31
05/07/21
05/07
15:31
05/07/21
15:31
FDUS

Fidus Investment

$17.76 /

+0.36 (+2.07%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDUS Fidus Investment
$17.76 /

+0.36 (+2.07%)

03/01/21 Keefe Bruyette
Fidus upgraded to Outperform after 'strong' 2020 at Keefe Bruyette
03/01/21 B. Riley Securities
Fidus Investment price target raised to $16.50 from $14.50 at B. Riley
03/01/21 Keefe Bruyette
Fidus Investment upgraded to Outperform from Market Perform at Keefe Bruyette
11/24/20 B. Riley Securities
Fidus Investment price target raised to $12 from $10 at B. Riley Securities
FDUS Fidus Investment
$17.76 /

+0.36 (+2.07%)

Recommendations
Peloton price target lowered to $135 from $180 at JMP Securities » 15:27
05/07/21
05/07
15:27
05/07/21
15:27
PTON

Peloton

$84.01 /

+0.21 (+0.25%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTON Peloton
$84.01 /

+0.21 (+0.25%)

PTON Peloton
$84.01 /

+0.21 (+0.25%)

09:28 Today Truist
Peloton price target lowered to $125 from $160 at Truist
08:13 Today Stifel
Peloton price target lowered to $140 from $170 at Stifel
07:55 Today Canaccord
Peloton price target lowered to $150 from $180 at Canaccord
07:53 Today Wedbush
Peloton price target lowered to $114 from $120 at Wedbush
PTON Peloton
$84.01 /

+0.21 (+0.25%)

PTON Peloton
$84.01 /

+0.21 (+0.25%)

PTON Peloton
$84.01 /

+0.21 (+0.25%)

PTON Peloton
$84.01 /

+0.21 (+0.25%)

Conference/Events
VSE Corp. management to meet virtually with Benchmark » 15:26
05/07/21
05/07
15:26
05/07/21
15:26
VSEC

VSE Corp.

$43.72 /

+0.385 (+0.89%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VSEC VSE Corp.
$43.72 /

+0.385 (+0.89%)

VSEC VSE Corp.
$43.72 /

+0.385 (+0.89%)

05/05/21
Fly Intel: Top five analyst initiations
05/05/21 B. Riley
B. Riley starts VSE with Buy, says 'flying under the radar'
05/05/21 B. Riley
VSE Corp. initiated with a Buy at B. Riley
03/19/21 Canaccord
VSE Corp. price target raised to $52 from $48 at Canaccord
VSEC VSE Corp.
$43.72 /

+0.385 (+0.89%)

  • 29
    Jan
VSEC VSE Corp.
$43.72 /

+0.385 (+0.89%)

Conference/Events
Herman Miller participates in a conference call with Benchmark » 15:25
05/07/21
05/07
15:25
05/07/21
15:25
MLHR

Herman Miller

$43.82 /

+0.42 (+0.97%)

Conference call with CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MLHR Herman Miller
$43.82 /

+0.42 (+0.97%)

MLHR Herman Miller
$43.82 /

+0.42 (+0.97%)

09/18/20 Benchmark
Herman Miller price target raised to $40 from $30 at Benchmark
09/17/20 Sidoti
Herman Miller price target raised to $50 from $33 at Sidoti
06/30/20 Sidoti
Herman Miller upgraded to Buy from Neutral at Sidoti
05/22/20 Benchmark
Herman Miller initiated with a Buy at Benchmark
MLHR Herman Miller
$43.82 /

+0.42 (+0.97%)

MLHR Herman Miller
$43.82 /

+0.42 (+0.97%)

MLHR Herman Miller
$43.82 /

+0.42 (+0.97%)

Recommendations
Immunic price target raised to $56 from $55 at JMP Securities » 15:25
05/07/21
05/07
15:25
05/07/21
15:25
IMUX

Immunic

$12.77 /

+0.9 (+7.58%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMUX Immunic
$12.77 /

+0.9 (+7.58%)

IMUX Immunic
$12.77 /

+0.9 (+7.58%)

04/15/21 Piper Sandler
Piper Sandler 'very encouraged' by Immunic Phase 2 EMPhASIS cohort 2 data
04/15/21 Aegis
Immunic initiated with a Buy at Aegis
03/24/21
Fly Intel: Top five analyst initiations
03/24/21 JMP Securities
Immunic initiated with an Outperform at JMP Securities
  • 05
    Aug
  • 10
    Jun
IMUX Immunic
$12.77 /

+0.9 (+7.58%)

Recommendations
Granite Point Mortgage price target raised to $14 from $13 at JMP Securities » 15:23
05/07/21
05/07
15:23
05/07/21
15:23
GPMT

Granite Point Mortgage

$13.27 /

+0.22 (+1.69%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPMT Granite Point Mortgage
$13.27 /

+0.22 (+1.69%)

GPMT Granite Point Mortgage
$13.27 /

+0.22 (+1.69%)

04/26/21 JPMorgan
Granite Point Mortgage price target raised to $12 from $10 at JPMorgan
Recommendations
Carvana price target raised to $326 from $290 at JMP Securities » 15:21
05/07/21
05/07
15:21
05/07/21
15:21
CVNA

Carvana

$250.50 /

-12.83 (-4.87%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$250.50 /

-12.83 (-4.87%)

CVNA Carvana
$250.50 /

-12.83 (-4.87%)

05/03/21
Fly Intel: Top five analyst upgrades
05/03/21 BofA
Carvana upgraded to Buy at BofA amid tighter new auto supply
05/03/21 BofA
Carvana upgraded to Buy from Neutral at BofA
04/07/21 Raymond James
Carvana initiated with a Market Perform at Raymond James
CVNA Carvana
$250.50 /

-12.83 (-4.87%)

  • 02
    Dec
  • 19
    May
CVNA Carvana
$250.50 /

-12.83 (-4.87%)

CVNA Carvana
$250.50 /

-12.83 (-4.87%)

CVNA Carvana
$250.50 /

-12.83 (-4.87%)

Options
McEwen Mining options imply 14.9% move in share price post-earnings » 15:19
05/07/21
05/07
15:19
05/07/21
15:19
MUX

McEwen Mining

$1.30 /

+0.05 (+4.00%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MUX McEwen Mining
$1.30 /

+0.05 (+4.00%)

MUX McEwen Mining
$1.30 /

+0.05 (+4.00%)

09/29/20 Alliance Global Partners
McEwen Mining transferred with a Buy at Alliance Global Partners
09/14/20 Roth Capital
McEwen Mining resumed with a Buy at Roth Capital
MUX McEwen Mining
$1.30 /

+0.05 (+4.00%)

MUX McEwen Mining
$1.30 /

+0.05 (+4.00%)

Technical Analysis
NASDAQ market internals summary » 15:17
05/07/21
05/07
15:17
05/07/21
15:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 15:16
05/07/21
05/07
15:16
05/07/21
15:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

General news
U.S. consumer credit rose $25.8 B in March » 15:15
05/07/21
05/07
15:15
05/07/21
15:15
$ECON

Economic Data

/

+

U.S. consumer credit rose…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Conference/Events
    Hubbell participates in a conference call with Stephens » 15:10
    05/07/21
    05/07
    15:10
    05/07/21
    15:10
    HUBB

    Hubbell

    $199.77 /

    -0.04 (-0.02%)

    Conference call with CEO…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    HUBB Hubbell
    $199.77 /

    -0.04 (-0.02%)

    HUBB Hubbell
    $199.77 /

    -0.04 (-0.02%)

    10/27/20 Stephens
    Hubbell price target raised to $180 from $175 at Stephens
    10/15/20 Stephens
    Hubbell resumed with an Overweight at Stephens
    09/15/20 UBS
    Hubbell initiated with a Neutral at UBS
    HUBB Hubbell
    $199.77 /

    -0.04 (-0.02%)

    Conference/Events
    Kirby management to meet virtually with Stephens » 15:09
    05/07/21
    05/07
    15:09
    05/07/21
    15:09
    KEX

    Kirby

    $67.67 /

    +0.67 (+1.00%)

    Virtual Meeting to be…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    KEX Kirby
    $67.67 /

    +0.67 (+1.00%)

    KEX Kirby
    $67.67 /

    +0.67 (+1.00%)

    09:30 Today Gabelli
    Kirby downgraded to Hold at Gabelli on decelerating earnings growth after 2023
    08:38 Today Gabelli
    Kirby downgraded to Hold from Buy at Gabelli
    11/18/20 BofA
    Kirby upgraded to Buy at BofA on refinery utilization increase potential
    11/18/20 BofA
    Kirby upgraded to Buy from Neutral at BofA
    KEX Kirby
    $67.67 /

    +0.67 (+1.00%)

    General news
    March consumer credit up $25.8B vs. last month, consensus $17.7B  15:08
    05/07/21
    05/07
    15:08
    05/07/21
    15:08
    $ECON

    Economic Data

    /

    +

     
    ShowHide Related Items >><<
      Options
      U S Global Investors options imply 10.6% move in share price post-earnings » 15:04
      05/07/21
      05/07
      15:04
      05/07/21
      15:04
      GROW

      U.S. Global Investors

      $7.38 /

      +0.165 (+2.29%)

      Pre-earnings options…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      GROW U.S. Global Investors
      $7.38 /

      +0.165 (+2.29%)

      On The Fly
      Short Interest Report: Bearish positioning on Washington Federal, iRobot jump » 14:59
      05/07/21
      05/07
      14:59
      05/07/21
      14:59
      WAFD

      Washington Federal

      $33.02 /

      -0.15 (-0.45%)

      , IRBT

      iRobot

      $96.56 /

      -1.86 (-1.89%)

      , MVIS

      MicroVision

      $14.14 /

      +0.14 (+1.00%)

      , M

      Macy's

      $17.61 /

      +0.285 (+1.65%)

      , DAC

      Danaos

      $64.70 /

      +1.43 (+2.26%)

      , PGEN

      Precigen

      $6.52 /

      -0.08 (-1.21%)

      , BRN

      Barnwell Industries

      $2.88 /

      -0.12 (-4.00%)

      , IWF

      iShares Russell 1000 Growth

      $256.38 /

      +1.39 (+0.55%)

      , IWD

      iShares Russell 1000 Value

      $161.70 /

      +1.19 (+0.74%)

      Welcome to this week’s…

      ShowHide Related Items >><<
      WAFD Washington Federal
      $33.02 /

      -0.15 (-0.45%)

      IRBT iRobot
      $96.56 /

      -1.86 (-1.89%)

      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      DAC Danaos
      $64.70 /

      +1.43 (+2.26%)

      PGEN Precigen
      $6.52 /

      -0.08 (-1.21%)

      BRN Barnwell Industries
      $2.88 /

      -0.12 (-4.00%)

      WAFD Washington Federal
      $33.02 /

      -0.15 (-0.45%)

      IRBT iRobot
      $96.56 /

      -1.86 (-1.89%)

      02/12/21 Northland
      iRobot price target raised to $140 from $120 at Northland
      02/12/21 Citi
      iRobot price target raised to $140 from $95 at Citi
      02/11/21 JPMorgan
      iRobot upgraded to Overweight from Neutral at JPMorgan
      02/11/21 JPMorgan
      iRobot upgraded to Overweight from Neutral at JPMorgan
      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      04/19/21 JPMorgan
      Macy's price target raised to $16 from $15 at JPMorgan
      03/12/21 Jefferies
      Jefferies picks Macy's, Kohl's and Nordstrom as department store 'survivors'
      02/24/21 Credit Suisse
      Macy's price target raised to $13 from $7 at Credit Suisse
      02/24/21 Deutsche Bank
      Macy's price target raised to $16 from $15 at Deutsche Bank
      DAC Danaos
      $64.70 /

      +1.43 (+2.26%)

      03/29/21 Fearnley
      Danaos initiated with a Buy at Fearnley
      12/09/20 Jefferies
      Danaos price target raised to $18 from $13 at Jefferies
      09/28/20 Citi
      Danaos price target raised to $6.25 from $4.75 at Citi
      PGEN Precigen
      $6.52 /

      -0.08 (-1.21%)

      03/02/21 B. Riley Securities
      Precigen price target raised to $14 from $10 at B. Riley Securities
      02/25/21 Stifel
      Precigen initiated with a Buy at Stifel
      02/22/21 Wells Fargo
      Precigen initiated with an Overweight at Wells Fargo
      02/18/21
      Fly Intel: Top five analyst initiations
      BRN Barnwell Industries
      $2.88 /

      -0.12 (-4.00%)

      IWF iShares Russell 1000 Growth
      $256.38 /

      +1.39 (+0.55%)

      IWD iShares Russell 1000 Value
      $161.70 /

      +1.19 (+0.74%)

      WAFD Washington Federal
      $33.02 /

      -0.15 (-0.45%)

      IRBT iRobot
      $96.56 /

      -1.86 (-1.89%)

      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      PGEN Precigen
      $6.52 /

      -0.08 (-1.21%)

      • 22
        Jan
      • 24
        Nov
      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      IRBT iRobot
      $96.56 /

      -1.86 (-1.89%)

      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      DAC Danaos
      $64.70 /

      +1.43 (+2.26%)

      PGEN Precigen
      $6.52 /

      -0.08 (-1.21%)

      BRN Barnwell Industries
      $2.88 /

      -0.12 (-4.00%)

      IWF iShares Russell 1000 Growth
      $256.38 /

      +1.39 (+0.55%)

      IWD iShares Russell 1000 Value
      $161.70 /

      +1.19 (+0.74%)

      WAFD Washington Federal
      $33.02 /

      -0.15 (-0.45%)

      IRBT iRobot
      $96.56 /

      -1.86 (-1.89%)

      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      DAC Danaos
      $64.70 /

      +1.43 (+2.26%)

      PGEN Precigen
      $6.52 /

      -0.08 (-1.21%)

      Recommendations
      Tabula Rasa price target raised to $45 from $41 at Piper Sandler » 14:49
      05/07/21
      05/07
      14:49
      05/07/21
      14:49
      TRHC

      Tabula Rasa HealthCare

      $47.06 /

      +4.89 (+11.60%)

      Piper Sandler analyst…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      TRHC Tabula Rasa HealthCare
      $47.06 /

      +4.89 (+11.60%)

      TRHC Tabula Rasa HealthCare
      $47.06 /

      +4.89 (+11.60%)

      03/01/21
      Fly Intel: Top five analyst downgrades
      03/01/21 Truist
      Tabula Rasa HealthCare downgraded to Hold from Buy at Truist
      03/01/21 Truist
      Tabula Rasa HealthCare downgraded to Hold from Buy at Truist
      02/24/21 Piper Sandler
      Tabula Rasa HealthCare downgraded to Neutral from Overweight at Piper Sandler
      TRHC Tabula Rasa HealthCare
      $47.06 /

      +4.89 (+11.60%)

      Get Full Fly Access

      Breaking market intelligence sent straight to you
      Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
      Up-to-date information on important industry events
      Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
      News focused on the companies in your portfolio
      Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.